You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues
|
|---|---|
| Published in |
Molecular Cancer, February 2019
|
| DOI | 10.1186/s12943-019-0950-1 |
| Pubmed ID | |
| Authors |
Hongqing Zhuang, Siyu Shi, Zhiyong Yuan, Joe Y. Chang |
X Demographics
The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 29% |
| Spain | 1 | 14% |
| Italy | 1 | 14% |
| Unknown | 3 | 43% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 92 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 92 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 9 | 10% |
| Student > Ph. D. Student | 9 | 10% |
| Student > Postgraduate | 9 | 10% |
| Researcher | 7 | 8% |
| Student > Doctoral Student | 6 | 7% |
| Other | 13 | 14% |
| Unknown | 39 | 42% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 35 | 38% |
| Neuroscience | 5 | 5% |
| Engineering | 3 | 3% |
| Biochemistry, Genetics and Molecular Biology | 2 | 2% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 2% |
| Other | 6 | 7% |
| Unknown | 39 | 42% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 December 2022.
All research outputs
#5,439,065
of 25,380,089 outputs
Outputs from Molecular Cancer
#443
of 1,915 outputs
Outputs of similar age
#115,009
of 448,077 outputs
Outputs of similar age from Molecular Cancer
#13
of 29 outputs
Altmetric has tracked 25,380,089 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,915 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,077 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.